Works matching IS 11738804 AND DT 2021 AND VI 35 AND IP 6

Results: 10

Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 715, doi. 10.1007/s40259-021-00507-5

By:

Bots, Steven J.;
Parker, Claire E.;
Brandse, Johannan F.;
Löwenberg, Mark;
Feagan, Brian G.;
Sandborn, William J.;
Jairath, Vipul;
D'Haens, Geert;
Vande Casteele, Niels

Publication type:

Article

Acknowledgement to Referees.

Published in:: BioDrugs, 2021, v. 35, n. 6, p. 589, doi. 10.1007/s40259-021-00506-6
Publication type:: Article

Targeted Therapy for Primary Sjögren's Syndrome: Where are We Now?

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 593, doi. 10.1007/s40259-021-00505-7

By:

Wang, Bin;
Chen, Shiju;
Li, Yan;
Xuan, Jingxiu;
Liu, Yuan;
Shi, Guixiu

Publication type:

Article

Nerve Growth Factor (NGF) Inhibitors and Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review.

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 611, doi. 10.1007/s40259-021-00504-8

By:

Oo, Win Min;
Hunter, David J

Publication type:

Article

Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design.

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 693, doi. 10.1007/s40259-021-00503-9

By:

Rivera-Ordaz, Araceli;
Peli, Valeria;
Manzini, Paolo;
Barilani, Mario;
Lazzari, Lorenza

Publication type:

Article

Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study.

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 735, doi. 10.1007/s40259-021-00502-w

By:

Feldman, Steven R.;
Reznichenko, Nataliya;
Pulka, Grazyna;
Kingo, Külli;
George Galdava;
Berti, Fausto;
Sobierska, Joanna;
Dias, Roshan;
Guenzi, Eric;
Hendrik Otto;
Haliduola, Halimu N.;
Kay, Richard;
Stroissnig, Heimo

Publication type:

Article

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept.

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 765, doi. 10.1007/s40259-021-00501-x

By:

Meijboom, Rosanne W.;
Gardarsdottir, Helga;
Becker, Matthijs L.;
ten Wolde, Saskia;
Egberts, Toine C. G.;
Giezen, Thijs J.

Publication type:

Article

Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy.

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 643, doi. 10.1007/s40259-021-00500-y

By:

Marschall, Andrea L. J.

Publication type:

Article

Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update.

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 673, doi. 10.1007/s40259-021-00499-2

By:

Parravano, Mariacristina;
Costanzo, Eliana;
Scondotto, Giulia;
Trifirò, Gianluca;
Virgili, Gianni

Publication type:

Article

Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project.

Published in:

BioDrugs, 2021, v. 35, n. 6, p. 749, doi. 10.1007/s40259-021-00498-3

By:

Trifirò, Gianluca;
Isgrò, Valentina;
Ingrasciotta, Ylenia;
Ientile, Valentina;
L'Abbate, Luca;
Foti, Saveria S.;
Belleudi, Valeria;
Poggi, Francesca;
Fontana, Andrea;
Moretti, Ugo;
Lora, Riccardo;
Sabaini, Alberto;
Senesi, Ilenia;
Sorrentino, Carla;
Puzo, Maria R.;
Padula, Angela;
Fusco, Mariano;
Giordana, Roberta;
Solfrini, Valentina;
Puccini, Aurora

Publication type:

Article